Objective
Analyze AI impact and agreement patterns within specific subgroups defined by tumor characteristics.
Note for Pathologist: Breast cancer is not one disease. We break down the performance by molecular subtype (e.g., Triple Negative vs Luminal A) and by “borderline” status (e.g., Ki67 near 20-30%). This ensures we don’t claim “Good Accuracy” overall while hiding poor performance in the most critical, difficult subgroups.
Agreement by Molecular Subtype
Does inter-observer agreement vary by molecular subtype?
| ICC Values for Continuous Markers |
| HER2 Positive |
324 |
0.971 |
0.936 |
0.933 |
| Hormone Weak Positive |
189 |
0.415 |
0.993 |
0.851 |
| Luminal A |
390 |
0.655 |
0.818 |
0.670 |
| Luminal B |
146 |
0.735 |
0.953 |
0.767 |
| Triple Negative |
135 |
NaN |
NaN |
0.949 |
| ICC Values for Continuous Markers |
| HER2 Positive |
292 |
0.984 |
0.975 |
0.921 |
| Hormone Weak Positive |
173 |
0.784 |
0.991 |
0.890 |
| Luminal A |
310 |
0.424 |
0.946 |
0.647 |
| Luminal B |
268 |
0.969 |
0.976 |
0.783 |
| Triple Negative |
141 |
NaN |
NaN |
0.939 |
Note for Pathologist: ICC values are shown separately for each molecular subtype. Low ICC (below 0.75) suggests poor agreement within that subgroup. If ICC improves from Pre-AI to Post-AI for a given subtype, it means AI helped pathologists agree more on cases of that type. Subtypes with very few cases (small N) may produce unreliable ICC estimates.
AI Impact by HER2 Status
Compare AI influence in HER2 positive vs negative cases.
| Mean absolute changes in marker values |
| HER2 Negative |
783 |
3.07 |
4.54 |
6.76 |
6.63 |
| HER2 Positive/Equivocal |
324 |
3.09 |
2.89 |
7.29 |
15.36 |
Agreement in Hormone Receptor Positive vs Negative
| ICC comparison in HR+ vs HR- cases |
| HR Negative |
193 |
NaN |
NaN |
0.950 |
Pre-AI |
| HR Positive |
988 |
0.815 |
0.943 |
0.900 |
Pre-AI |
| HR Negative |
180 |
NaN |
NaN |
0.927 |
Post-AI |
| HR Positive |
994 |
0.917 |
0.969 |
0.911 |
Post-AI |
Ki67 Proliferation Categories
Analyze agreement in high vs low proliferation cases.
| Pre-AI vs Post-AI ICC values |
| High (≥30%) |
399 |
0.978 |
0.989 |
0.943 |
0.964 |
0.881 |
0.868 |
| Intermediate (20-30%) |
193 |
0.923 |
0.954 |
0.948 |
0.893 |
0.745 |
0.523 |
| Low (<20%) |
583 |
0.913 |
0.947 |
0.963 |
0.979 |
0.707 |
0.700 |
| Mean absolute changes and subtype reclassification |
| High (≥30%) |
399 |
3.00 |
2.63 |
7.62 |
9.77 |
| Intermediate (20-30%) |
193 |
3.18 |
4.89 |
8.84 |
44.56 |
| Low (<20%) |
583 |
3.03 |
4.84 |
5.72 |
13.55 |
Borderline Cases Analysis
Focus on cases near clinical thresholds where AI impact may be most critical.
Note for Pathologist: “Borderline” cases sit near critical clinical cutoffs (e.g., ER 0-10%, Ki67 25-35%, HER2 Score 2). These are the cases where small changes in scoring can change the treatment plan entirely. If AI improves agreement in borderline cases specifically, it provides the greatest clinical value.
Borderline case statistics:
ER borderline (0-10%): 228
PR borderline (0-10%): 634
Ki67 borderline (25-35%): 193
HER2 borderline (Score 2): 192
| Cases near clinical thresholds |
| 341 |
3.38 |
7.90 |
7.09 |
6.42 |
19.06 |
Non-Borderline |
| 799 |
2.95 |
2.30 |
6.83 |
10.54 |
16.65 |
Borderline |
| 44 |
2.98 |
7.39 |
6.13 |
0.00 |
13.64 |
NA |
| ICC values comparing borderline vs non-borderline |
| 341 |
0.410 |
0.604 |
0.804 |
0.864 |
0.933 |
0.918 |
Non-Borderline |
| 799 |
0.973 |
0.987 |
0.929 |
0.958 |
0.944 |
0.946 |
Borderline |
| 44 |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
Triple Negative Cases
Special focus on triple negative breast cancer (TNBC) cases. TNBC is characterized by aggressive behavior and lack of targeted therapies, making accurate biomarker assessment and identification of potential responders to chemotherapy (e.g., via Ki67) critical. AI approaches have been highlighted as promising tools for refining prognosis and prediction in this subgroup (Corredor et al. 2023).
Any TNBC designation: 143
Cases reclassified to/from TNBC: 10
| Cases that changed to or from Triple Negative status |
| 21524-25 |
Pathologist 2 |
Triple Negative |
Hormone Weak Positive |
0.0 |
1.0 |
0.0 |
0.0 |
1 |
1 |
| 18413-25 |
Pathologist 2 |
HER2 Positive |
Triple Negative |
0.0 |
0.0 |
0.0 |
0.0 |
2 |
1 |
| 14982-25 |
Pathologist 2 |
HER2 Positive |
Triple Negative |
0.0 |
0.0 |
0.0 |
0.0 |
2 |
1 |
| 9229-25 |
Pathologist 2 |
Luminal A |
Triple Negative |
90.0 |
NA |
10.0 |
NA |
1 |
NA |
| 6476-25 |
Pathologist 2 |
HER2 Positive |
Triple Negative |
0.0 |
0.0 |
0.0 |
0.0 |
2 |
1 |
| 25564-25 |
Pathologist 1 |
HER2 Positive |
Triple Negative |
0.0 |
0.0 |
0.0 |
0.0 |
2 |
1 |
| 11985-25 |
Pathologist 1 |
Triple Negative |
Hormone Weak Positive |
0.0 |
2.0 |
0.0 |
0.0 |
0 |
0 |
| 16127-25 |
Pathologist 3 |
Luminal A |
Triple Negative |
80.0 |
NA |
60.0 |
NA |
1 |
NA |
| 14982-25 |
Pathologist 3 |
HER2 Positive |
Triple Negative |
0.0 |
0.0 |
0.0 |
0.0 |
2 |
NA |
| 11354-25 |
Pathologist 3 |
Luminal A |
Triple Negative |
90.0 |
NA |
20.0 |
NA |
1 |
NA |
# A tibble: 1 × 7
n_cases er_icc_pre er_icc_post pr_icc_pre pr_icc_post ki67_icc_pre
<int> <dbl> <dbl> <dbl> <dbl> <dbl>
1 143 NaN -0.00868 NaN NaN 0.949
# ℹ 1 more variable: ki67_icc_post <dbl>
Luminal A vs B Differentiation
Focus on cases where Ki67 determines Luminal subtype.
Luminal A/B reclassifications: 85
| Cases that switched between Luminal subtypes |
| 33681-25 |
Pathologist 2 |
Luminal B |
Luminal A |
35.0 |
25.0 |
50.0 |
50.0 |
30.0 |
30.0 |
| 32252-25 |
Pathologist 2 |
Luminal A |
Luminal B |
25.0 |
33.0 |
100.0 |
100.0 |
100.0 |
90.0 |
| 31276-25 |
Pathologist 2 |
Luminal A |
Luminal B |
29.0 |
30.0 |
100.0 |
100.0 |
70.0 |
55.0 |
| 31467-25 |
Pathologist 2 |
Luminal A |
Luminal B |
20.0 |
30.0 |
95.0 |
95.0 |
50.0 |
60.0 |
| 30689-25 |
Pathologist 2 |
Luminal A |
Luminal B |
23.0 |
35.0 |
95.0 |
100.0 |
80.0 |
85.0 |
| 24570-25 |
Pathologist 2 |
Luminal A |
Luminal B |
23.0 |
32.0 |
90.0 |
89.0 |
60.0 |
41.0 |
| 21963-25 |
Pathologist 2 |
Luminal A |
Luminal B |
27.0 |
37.0 |
95.0 |
95.0 |
95.0 |
95.0 |
| 20823-25 |
Pathologist 2 |
Luminal A |
Luminal B |
21.0 |
30.0 |
80.0 |
77.0 |
60.0 |
54.0 |
| 18676-25 |
Pathologist 2 |
Luminal A |
Luminal B |
27.0 |
40.0 |
90.0 |
93.0 |
30.0 |
17.0 |
| 15305-25 |
Pathologist 2 |
Luminal A |
Luminal B |
28.0 |
44.0 |
90.0 |
86.0 |
70.0 |
69.0 |
| 14815-25 |
Pathologist 2 |
Luminal A |
Luminal B |
28.0 |
30.0 |
100.0 |
95.0 |
50.0 |
45.0 |
| 14262-25 |
Pathologist 2 |
Luminal A |
Luminal B |
25.0 |
35.0 |
95.0 |
95.0 |
30.0 |
20.0 |
| 11354-25 |
Pathologist 2 |
Luminal A |
Luminal B |
25.0 |
31.0 |
95.0 |
95.0 |
40.0 |
25.0 |
| 9346-25 |
Pathologist 2 |
Luminal A |
Luminal B |
16.0 |
30.0 |
90.0 |
92.0 |
40.0 |
50.0 |
| 6444-25 |
Pathologist 2 |
Luminal A |
Luminal B |
25.0 |
50.0 |
90.0 |
90.0 |
90.0 |
80.0 |
| 33988-25 |
Pathologist 1 |
Luminal A |
Luminal B |
6.0 |
32.0 |
95.0 |
97.0 |
95.0 |
97.0 |
| 33813-25 |
Pathologist 1 |
Luminal B |
Luminal A |
32.0 |
21.0 |
95.0 |
99.0 |
100.0 |
99.0 |
| 32396-25 |
Pathologist 1 |
Luminal A |
Luminal B |
20.0 |
30.0 |
95.0 |
98.0 |
50.0 |
50.0 |
| 31448-25 |
Pathologist 1 |
Luminal A |
Luminal B |
26.0 |
37.0 |
90.0 |
91.0 |
50.0 |
47.0 |
| 30689-25 |
Pathologist 1 |
Luminal A |
Luminal B |
8.0 |
35.0 |
95.0 |
89.0 |
40.0 |
59.0 |
| 29103-25 |
Pathologist 1 |
Luminal A |
Luminal B |
24.0 |
69.0 |
100.0 |
96.0 |
80.0 |
63.0 |
| 28463-25 |
Pathologist 1 |
Luminal A |
Luminal B |
22.0 |
45.0 |
70.0 |
45.0 |
30.0 |
43.0 |
| 26562-25 |
Pathologist 1 |
Luminal A |
Luminal B |
12.0 |
45.0 |
95.0 |
95.0 |
70.0 |
55.0 |
| 24570-25 |
Pathologist 1 |
Luminal A |
Luminal B |
23.0 |
32.0 |
90.0 |
90.0 |
50.0 |
40.0 |
| 21963-25 |
Pathologist 1 |
Luminal A |
Luminal B |
15.0 |
34.0 |
85.0 |
90.0 |
90.0 |
90.0 |
| 22030-25 |
Pathologist 1 |
Luminal A |
Luminal B |
16.0 |
35.0 |
95.0 |
95.0 |
95.0 |
80.0 |
| 20019-25 |
Pathologist 1 |
Luminal A |
Luminal B |
16.0 |
30.0 |
100.0 |
95.0 |
95.0 |
79.0 |
| 18267-25 |
Pathologist 1 |
Luminal A |
Luminal B |
11.0 |
31.0 |
95.0 |
92.0 |
60.0 |
42.0 |
| 16396-25 |
Pathologist 1 |
Luminal A |
Luminal B |
24.0 |
45.0 |
95.0 |
98.0 |
80.0 |
70.0 |
| 16497-25 |
Pathologist 1 |
Luminal A |
Luminal B |
15.0 |
30.0 |
90.0 |
93.0 |
60.0 |
70.0 |
| 14815-25 |
Pathologist 1 |
Luminal A |
Luminal B |
28.0 |
30.0 |
95.0 |
95.0 |
70.0 |
50.0 |
| 14987-25 |
Pathologist 1 |
Luminal A |
Luminal B |
26.0 |
44.0 |
80.0 |
92.0 |
15.0 |
9.0 |
| 14262-25 |
Pathologist 1 |
Luminal A |
Luminal B |
25.0 |
36.0 |
90.0 |
95.0 |
30.0 |
19.0 |
| 14074-25 |
Pathologist 1 |
Luminal A |
Luminal B |
12.0 |
37.0 |
90.0 |
92.0 |
90.0 |
86.0 |
| 13388-25 |
Pathologist 1 |
Luminal A |
Luminal B |
15.0 |
32.0 |
95.0 |
96.0 |
95.0 |
96.0 |
| 13472-25 |
Pathologist 1 |
Luminal A |
Luminal B |
24.0 |
30.0 |
70.0 |
94.0 |
50.0 |
58.0 |
| 11625-25 |
Pathologist 1 |
Luminal A |
Luminal B |
12.0 |
40.0 |
95.0 |
82.0 |
95.0 |
70.0 |
| 10928-25 |
Pathologist 1 |
Luminal A |
Luminal B |
10.0 |
35.0 |
95.0 |
86.0 |
70.0 |
48.0 |
| 9753-25 |
Pathologist 1 |
Luminal A |
Luminal B |
11.0 |
30.0 |
90.0 |
94.0 |
80.0 |
71.0 |
| 7121-25 |
Pathologist 1 |
Luminal A |
Luminal B |
27.0 |
38.0 |
90.0 |
95.0 |
30.0 |
17.0 |
| 6288-25 |
Pathologist 1 |
Luminal A |
Luminal B |
13.0 |
30.0 |
95.0 |
90.0 |
95.0 |
73.0 |
| 33836-25 |
Pathologist 4 |
Luminal A |
Luminal B |
29.0 |
40.0 |
95.0 |
95.0 |
90.0 |
90.0 |
| 33988-25 |
Pathologist 4 |
Luminal A |
Luminal B |
28.0 |
31.0 |
95.0 |
95.0 |
90.0 |
90.0 |
| 32396-25 |
Pathologist 4 |
Luminal A |
Luminal B |
20.0 |
40.0 |
95.0 |
95.0 |
80.0 |
70.0 |
| 32252-25 |
Pathologist 4 |
Luminal A |
Luminal B |
27.0 |
33.0 |
95.0 |
95.0 |
95.0 |
90.0 |
| 31276-25 |
Pathologist 4 |
Luminal A |
Luminal B |
25.0 |
34.0 |
95.0 |
95.0 |
50.0 |
50.0 |
| 30689-25 |
Pathologist 4 |
Luminal A |
Luminal B |
18.0 |
34.0 |
95.0 |
95.0 |
90.0 |
90.0 |
| 28463-25 |
Pathologist 4 |
Luminal A |
Luminal B |
22.0 |
45.0 |
95.0 |
80.0 |
40.0 |
50.0 |
| 24570-25 |
Pathologist 4 |
Luminal A |
Luminal B |
23.0 |
32.0 |
95.0 |
90.0 |
40.0 |
40.0 |
| 22438-25 |
Pathologist 4 |
Luminal A |
Luminal B |
28.0 |
30.0 |
95.0 |
95.0 |
90.0 |
95.0 |
| 20019-25 |
Pathologist 4 |
Luminal A |
Luminal B |
16.0 |
30.0 |
95.0 |
95.0 |
95.0 |
90.0 |
| 18217-25 |
Pathologist 4 |
Luminal A |
Luminal B |
22.0 |
36.0 |
95.0 |
95.0 |
70.0 |
70.0 |
| 17530-25 |
Pathologist 4 |
Luminal A |
Luminal B |
28.0 |
35.0 |
80.0 |
80.0 |
60.0 |
70.0 |
| 16396-25 |
Pathologist 4 |
Luminal A |
Luminal B |
24.0 |
55.0 |
95.0 |
95.0 |
70.0 |
70.0 |
| 16497-25 |
Pathologist 4 |
Luminal A |
Luminal B |
15.0 |
30.0 |
90.0 |
90.0 |
70.0 |
70.0 |
| 15305-25 |
Pathologist 4 |
Luminal A |
Luminal B |
22.0 |
42.0 |
80.0 |
80.0 |
60.0 |
70.0 |
| 14815-25 |
Pathologist 4 |
Luminal A |
Luminal B |
28.0 |
30.0 |
95.0 |
95.0 |
60.0 |
60.0 |
| 14262-25 |
Pathologist 4 |
Luminal A |
Luminal B |
26.0 |
35.0 |
95.0 |
95.0 |
10.0 |
20.0 |
| 13388-25 |
Pathologist 4 |
Luminal A |
Luminal B |
20.0 |
32.0 |
95.0 |
95.0 |
95.0 |
95.0 |
| 11625-25 |
Pathologist 4 |
Luminal A |
Luminal B |
18.0 |
39.0 |
90.0 |
80.0 |
80.0 |
70.0 |
| 11354-25 |
Pathologist 4 |
Luminal A |
Luminal B |
21.0 |
30.0 |
95.0 |
90.0 |
30.0 |
20.0 |
| 9753-25 |
Pathologist 4 |
Luminal A |
Luminal B |
27.0 |
30.0 |
80.0 |
90.0 |
40.0 |
60.0 |
| 7121-25 |
Pathologist 4 |
Luminal A |
Luminal B |
28.0 |
34.0 |
95.0 |
95.0 |
40.0 |
30.0 |
| 33988-25 |
Pathologist 3 |
Luminal A |
Luminal B |
6.0 |
30.0 |
90.0 |
90.0 |
90.0 |
90.0 |
| 33813-25 |
Pathologist 3 |
Luminal B |
Luminal A |
30.0 |
21.0 |
90.0 |
90.0 |
90.0 |
90.0 |
| 32396-25 |
Pathologist 3 |
Luminal A |
Luminal B |
20.0 |
40.0 |
90.0 |
90.0 |
60.0 |
60.0 |
| 31448-25 |
Pathologist 3 |
Luminal A |
Luminal B |
26.0 |
40.0 |
80.0 |
80.0 |
60.0 |
40.0 |
| 31276-25 |
Pathologist 3 |
Luminal A |
Luminal B |
25.0 |
30.0 |
90.0 |
90.0 |
50.0 |
50.0 |
| 31467-25 |
Pathologist 3 |
Luminal A |
Luminal B |
7.0 |
30.0 |
90.0 |
90.0 |
50.0 |
60.0 |
| 30689-25 |
Pathologist 3 |
Luminal A |
Luminal B |
23.0 |
33.0 |
90.0 |
90.0 |
60.0 |
60.0 |
| 28463-25 |
Pathologist 3 |
Luminal A |
Luminal B |
22.0 |
40.0 |
90.0 |
70.0 |
50.0 |
40.0 |
| 26562-25 |
Pathologist 3 |
Luminal A |
Luminal B |
12.0 |
44.0 |
90.0 |
80.0 |
40.0 |
50.0 |
| 24570-25 |
Pathologist 3 |
Luminal A |
Luminal B |
10.0 |
32.0 |
90.0 |
90.0 |
20.0 |
30.0 |
| 21963-25 |
Pathologist 3 |
Luminal A |
Luminal B |
26.0 |
30.0 |
80.0 |
90.0 |
80.0 |
80.0 |
| 22030-25 |
Pathologist 3 |
Luminal A |
Luminal B |
16.0 |
30.0 |
80.0 |
90.0 |
70.0 |
80.0 |
| 20019-25 |
Pathologist 3 |
Luminal A |
Luminal B |
15.0 |
30.0 |
80.0 |
90.0 |
80.0 |
80.0 |
| 16396-25 |
Pathologist 3 |
Luminal A |
Luminal B |
23.0 |
30.0 |
90.0 |
95.0 |
80.0 |
70.0 |
| 14262-25 |
Pathologist 3 |
Luminal A |
Luminal B |
25.0 |
30.0 |
90.0 |
85.0 |
20.0 |
20.0 |
| 14095-25 |
Pathologist 3 |
Luminal A |
Luminal B |
10.0 |
30.0 |
90.0 |
90.0 |
30.0 |
40.0 |
| 13388-25 |
Pathologist 3 |
Luminal A |
Luminal B |
25.0 |
31.0 |
90.0 |
90.0 |
90.0 |
90.0 |
| 13472-25 |
Pathologist 3 |
Luminal A |
Luminal B |
25.0 |
30.0 |
90.0 |
90.0 |
60.0 |
60.0 |
| 10676-25 |
Pathologist 3 |
Luminal A |
Luminal B |
23.0 |
33.0 |
80.0 |
90.0 |
80.0 |
80.0 |
| 9753-25 |
Pathologist 3 |
Luminal A |
Luminal B |
20.0 |
30.0 |
80.0 |
80.0 |
80.0 |
70.0 |
| 7121-25 |
Pathologist 3 |
Luminal A |
Luminal B |
27.0 |
35.0 |
80.0 |
90.0 |
10.0 |
15.0 |
| 6288-25 |
Pathologist 3 |
Luminal A |
Luminal B |
15.0 |
30.0 |
70.0 |
60.0 |
50.0 |
50.0 |
| mean_ki67_pre |
mean_ki67_post |
median_ki67_pre |
median_ki67_post |
| 21.1 |
34.5 |
23.0 |
32.0 |
Conclusion
Key Findings from Subgroup Analysis
- Molecular Subtype Dependency:
- Agreement metrics vary substantially across molecular subtypes
- AI impact differs by subtype, with certain subtypes showing more changes
- HER2 Status Impact:
- HER2+ cases may show different agreement patterns than HER2- cases
- AI influence varies by HER2 status
- Hormone Receptor Status:
- HR+ and HR- cases show different baseline agreement levels
- AI may have differential impact based on HR status
- Proliferation Categories:
- Ki67 categories affect both agreement and AI influence
- High proliferation cases may be more challenging
- Borderline Cases:
- Cases near clinical thresholds warrant special attention
- AI impact is often strongest in borderline cases
- These cases have the highest clinical impact
- TNBC Identification:
- Reclassifications to/from TNBC are critically important
- Requires careful review due to treatment implications
- Luminal Subtype Differentiation:
- Ki67 cutoff at 30% drives Luminal A vs B classification
- AI-influenced Ki67 changes can significantly affect treatment decisions
Clinical Recommendations
- Subgroup-specific quality metrics should be monitored
- Borderline and reclassified cases require additional review
- AI performance should be validated separately for each subgroup
- Training data for AI should include adequate representation of all subgroups
Corredor, Germán, Satvika Bharadwaj, Tilak Pathak, Vidya Sankar Viswanathan, Paula Toro, and Anant Madabhushi. 2023.
“A Review of AI-Based Radiomics and Computational Pathology Approaches in Triple-Negative Breast Cancer: Current Applications and Perspectives.” Clinical Breast Cancer 23 (8): 800–812.
https://doi.org/10.1016/j.clbc.2023.06.004.